Life Sciences - Corporate
The corporate lawyers in our Life Sciences Group work with clients in all stages of development, from formation through exits, such as dispositions and public offerings. We also represent a range of investors, investment banks, venture capital firms and larger medical device and pharmaceutical companies. We provide practical counseling based on our industry-wide knowledge to start-up companies, assisting to build the company’s strategy in dealing with its internal structure and growth, as well as its investors, licensors, licensees, vendors and others. We develop creative structures to allow our clients form valuable strategic alliances, licenses and partnerships, domestically and abroad. We also help companies identify sources of capital from our network of experienced and knowledgeable investors.
Due to our strong private equity and emerging company practice, we have significant experience in representing life sciences companies and private equity investors in the full range of private and public financing transactions, in the U.S., UK, Germany and Italy including:
- mergers and acquisitions
- strategic alliances and partnerships
- licensings transactions
- venture capital and angel financing
- private placements
- public offerings
- PIPES, Regulation S, Rule 144A and equity line financings
Our lawyers also regularly advise public life sciences companies on their public disclosure obligations, securities trading issues and corporate governance issues, including on new compliance obligations under Sarbanes-Oxley, and in the UK, Germany and Italy.
We provide life sciences and pharmaceutical companies with sophisticated tax and corporate structuring services and strategies for corporate partnerships, mergers and acquisitions, spinoffs and reorganizations. We bring unique experience to cross border transactions.
Contacts
- Dennis J. White
617.535.4011
Send E-mail
